Document Detail

Costs of bleeds relating to acute coronary syndrome therapies.
MedLine Citation:
PMID:  20465368     Owner:  NLM     Status:  In-Process    
METHODS: Retrospective chart reviews of ACS patients experiencing decrease in Hb, puncture site, or bleeding requiring transfusion were conducted in hospitals in France, Germany, Italy, Spain and Sweden to determine the total length of stay (LOS), stay post-bleeding, procedures to identify the extent of bleeding, number and types of transfusion products, patient demographics, reason for hospital admission and disposition upon discharge. Country-specific costs were applied to estimate the average cost per patient by type of bleeding event.
RESULTS: Records of 158 ACS patients with the bleeding complications were examined (26.9% decrease in Hb, 35.5% puncture site, and 37.8% transfusion). The average LOS was 10.6 days for decreasing Hb, 7.7 days for puncture site bleeding, and 11.3 days for patients receiving transfusions due to these bleeding events. The average costs per patient ranged between €3,986 and €10,252. The LOS ranged widely both within and across countries.
LIMITATIONS: The study has a small sample size and costs are confounded by co-morbidities.
CONCLUSIONS: The estimated costs for decreasing Hb, puncture site bleeding and bleeding resulting in transfusions provide a tool for researchers to conduct economic analyses of bleeding events associated with therapies for ACS.
Alexander Bufe; Ferrari Emile; Laurent Drogoul; Josep Guindo Soldevila; Di Pasquale Giuseppe; Lettino Maddalena; Magnus Janzon; Ruth E Brown
Related Documents :
3032758 - Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirr...
1213658 - Extended somatostatin treatment of a patient with bleeding ulcer.
8542868 - Recombinant hirudin and front-loaded alteplase in acute myocardial infarction: final re...
18574268 - Hemorrhagic complications of anticoagulant and thrombolytic treatment: american college...
17090818 - Early revascularization and acc/aha guideline-compliant medical management improve left...
7709768 - The poor-responder patient in an in vitro fertilization-embryo transfer (ivf-et) program.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of medical economics     Volume:  13     ISSN:  1941-837X     ISO Abbreviation:  J Med Econ     Publication Date:  2010  
Date Detail:
Created Date:  2010-06-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9892255     Medline TA:  J Med Econ     Country:  England    
Other Details:
Languages:  eng     Pagination:  236-40     Citation Subset:  IM    
Universitaetsklinik der Universitat Witten/Herdecke, Wuppertal, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyper...
Next Document:  Involvement of high plasma corticosterone status and activation of brain regional serotonin metaboli...